At the time of writing, Mesoblast Ltd ADR [MESO] stock is trading at $14.63, down -12.71%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MESO shares have gain 24.40% over the last week, with a monthly amount glided 41.63%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Mesoblast Ltd ADR [NASDAQ: MESO] stock has seen the most recent analyst activity on September 24, 2024, when Maxim Group upgraded its rating to a Buy but kept the price target unchanged to $12 for it. Previously, Jefferies upgraded its rating to Buy on August 29, 2024. On July 23, 2024, upgrade upgraded it’s rating to Overweight and revised its price target to $11 on the stock. Jefferies upgraded its rating to a Buy. Maxim Group downgraded its rating to a Hold. William Blair downgraded its rating to Mkt Perform for this stock on August 04, 2023. In a note dated August 04, 2023, Piper Sandler downgraded an Neutral rating on this stock and revised its target price from $7 to $2.
For the past year, the stock price of Mesoblast Ltd ADR fluctuated between $1.61 and $19.15. Currently, Wall Street analysts expect the stock to reach $11.5 within the next 12 months. Mesoblast Ltd ADR [NASDAQ: MESO] shares were valued at $14.63 at the most recent close of the market. An investor can expect a potential drop of -21.39% based on the average MESO price forecast.
Analyzing the MESO fundamentals
According to Mesoblast Ltd ADR [NASDAQ:MESO], the company’s sales were 5.89M for trailing twelve months, which represents an -3.91% plunge. Gross Profit Margin for this corporation currently stands at -5.3% with Operating Profit Margin at -8.26%, Pretax Profit Margin comes in at -9.88%, and Net Profit Margin reading is -9.85%. To continue investigating profitability, this company’s Return on Assets is posted at -0.08, Equity is -0.11 and Total Capital is -0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.24.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 13.66 points at the first support level, and at 12.70 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.63, and for the 2nd resistance point, it is at 16.64.
Ratios To Look Out For
It is important to note that Mesoblast Ltd ADR [NASDAQ:MESO] has a current ratio of 1.18. Further, the Quick Ratio stands at 1.18, while the Cash Ratio is 0.85. Considering the valuation of this stock, the price to sales ratio is 284.73, the price to book ratio is 3.48.
